HELLA GMBH+CO. KGAA O.N./ DE000A13SX22 /
08/10/2024 17:35:06 | Var. -0.20 | Volume | Denaro17:35:06 | Lettera08/10/2024 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
86.30EUR | -0.23% | 3,775 Fatturato: 326,321.60 |
-Quantità in denaro: - | -Quantità in lettera: - | 9.6 bill.EUR | 0.82% | 36.30 |
Newsfile Corp
22:01
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common ...
Newsfile Corp
21:17
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of NANO Nuclea...
Newsfile Corp
21:13
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna
Newsfile Corp
20:48
Vici Health Sciences Announces Launch of Phase I, Phase II, and Phase III Clinical Supplies Manufact...
Newsfile Corp
20:29
Vici Health Sciences Expands Staff and Footprint in Maryland to Meet Growing Customer Demands
Newsfile Corp
19:33
Callenders Realty is a Platinum Sponsor at Centurion One Capital's 2nd Annual Bahamas Summit
Newsfile Corp
18:48
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Visa Inc. Investors to Inquire About Securities Class Ac...
Newsfile Corp
18:20
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before I...